Stelara®

INN: ustekinumab

Approved for use in:

Crohn’s Disease (moderate-severe)
Ulcerative Colitis (moderate-severe)

Type/Class

Originator Biologic

Delivery Route

Intravenous infusion, then subcutaneous injection

Health Canada Approval

2008

Storage

Refrigerate between 2 and 8°C, do not freeze, keep in original carton to protect from light, do not shake.

Use in Older Adults (65+)

Limited data; please consult your doctor.

Pregnancy Indication

No pattern of major birth defects has been observed; only use if benefits outweight risks.

Breastfeeding Indication

Effects not studied; please consult your doctor.

Pediatric Indication

Safety and efficacy not established.

Learn More

View the Stelara® product monograph.